Treatment Plan for Anxiety and Depression (Comorbid GAD and MDD)

Treatment Plans|20 min read|Updated
Try this template in My Clinical WriterDownload Template

Feedback on this template

anxiety-and-depression-treatment-plan

Please don’t include any client or patient details.

What Is a Treatment Plan for Comorbid Anxiety and Depression?

A treatment plan for comorbid anxiety and depression covers generalized anxiety disorder (GAD, ICD-10-CM F41.1) and major depressive disorder (MDD, F32.x for a single episode or F33.x for recurrent episodes) in one document. Each diagnosis gets its own goals and measurable objectives, tracked with its own measure: the GAD-7 for anxiety and the PHQ-9 for depression. Interventions that help both conditions are written once and linked to every goal they serve, and the plan records which condition treatment addresses first, and why.

The two conditions are worth planning together because they keep each other going. Worry about what might go wrong and rumination about what already has are close relatives; avoidance in anxiety and withdrawal in depression both shrink a client's life; and poor sleep feeds both. Yet they are not one problem. In the study that introduced the GAD-7, anxiety and depression symptoms often showed up in the same patients but behaved as two separate dimensions, each adding its own share of functional impairment (Spitzer, Kroenke, Williams and Löwe, 2006). A plan that folds them into one goal, or measures only one of them, can miss a condition that is not improving.

Diagnostic criteria for both disorders are set out in the DSM-5-TR. For plain-language overviews, see the American Psychiatric Association's What Are Anxiety Disorders? and What Is Depression? pages. For single-diagnosis plans, see the GAD treatment plan and the depression treatment plan.

When You Need It

  • After a diagnostic assessment supports both diagnoses, not while one of them is still only suspected
  • When a client in treatment for one condition develops the other, for example depression emerging during GAD treatment: update the existing plan rather than starting a second one
  • When a payer asks for a plan that justifies continued care for both conditions
  • At a scheduled review where the scores show one condition improving and the other stuck
  • When stepping care up or down: adding a medication referral, a group, or a more intensive level of care
  • When a presentation first coded as mixed or unspecified has been clarified into two diagnoses

Key Components

Both Diagnoses, Coded and Ordered

List each diagnosis with its ICD-10-CM code and title: F41.1 Generalized anxiety disorder, and the code for the depressive episode, such as F32.1 (single episode, moderate), F32.2 (single episode, severe without psychotic features), F33.1 (recurrent, moderate) or F33.2 (recurrent, severe without psychotic features). The single-episode (F32) and recurrent (F33) categories exclude each other, so use one or the other.

On claims, ICD-10-CM's outpatient guidelines work visit by visit: list first the condition "shown in the medical record to be chiefly responsible for the services provided," then code every documented coexisting condition that requires or affects care (Sections IV.G and IV.J of the official guidelines). Most sessions work on the plan's lead condition, so most claims will list it first. A session spent mainly on the other condition is coded with that one first, so each note should make the session's main focus clear. Some EHRs copy the plan's diagnosis order onto every claim; check that yours lets you change it for a visit. On the plan itself, list the lead condition first and revise the order at a review. Neither order is a judgment about which diagnosis is more real.

The GAD code carries no severity, so the GAD-7 total and your narrative have to show how impairing the anxiety is. The depression code does carry severity, and later remission status, so update it when the episode changes.

A Formulation That Links the Two

Two or three sentences on how this client's anxiety and depression feed each other give the plan its logic and explain the shared interventions to anyone reading it. Name the specific links for this person: what they worry about, what they have stopped doing, how their sleep has changed, and what they tell themselves about it. For example: "Evening worry about the next workday delays sleep; short sleep worsens fatigue and low mood; low energy leads her to cancel plans; withdrawal leaves more time to ruminate, which feeds both hopelessness and the next day's worry." See case formulation examples and perpetuating factors for ways to write it.

Separate Goals for Each Diagnosis

Give each diagnosis at least one goal with its own objectives and measure, and consider a third goal for a problem both conditions feed. Number the goals in the order you will work on them, so the plan reads in the same order as the sessions:

  • Anxiety goal (F41.1). Reduce worry, physical tension and reassurance-seeking, and build tolerance of uncertainty. Measured with the GAD-7 plus a behavioral count, such as reassurance requests per day.
  • Depression goal (F32.x or F33.x). Lift mood and rebuild activity and social contact. Measured with the PHQ-9 plus an activity log.
  • Shared goal. Restore sleep, work attendance or a daily routine. Measured with a sleep diary or an attendance record.

Shared and Transdiagnostic Interventions

Many evidence-based interventions act on both conditions. Write each one once in the plan and note the goals it serves:

  • Cognitive behavioral therapy (CBT). The same restructuring skills work on threat-focused predictions ("I'll lose my job if this report has one mistake") and on hopeless or self-critical conclusions ("Nothing I do makes a difference"). Behavioral experiments test both kinds of prediction.
  • Behavioral activation. Scheduling valued and mastery activities counters depressive withdrawal, and the same schedule gives the client a way back into situations that anxiety has led them to avoid.
  • Strategies for repetitive negative thinking. Noticing when worry or rumination has started and shifting to problem solving or to the task in front of them; a scheduled worry period, with worries postponed to it at other times.
  • Problem-solving. Structured steps for the real stressors, such as money, work or relationships, that fuel both conditions.
  • Sleep and routine. A fixed wake time, stimulus control and a wind-down routine. When insomnia is a diagnosis in its own right, see CBT-I and the insomnia treatment plan.
  • Applied relaxation. For the physical tension of GAD. NICE's GAD guideline offers applied relaxation and CBT as its two high-intensity psychological treatments.
  • Mindfulness- and acceptance-based approaches. Mindfulness-based cognitive therapy for recurrent depression and acceptance and commitment therapy both change how the client relates to repetitive thoughts.

A unified, transdiagnostic protocol. Instead of running one manual for GAD and another for depression, some clinicians use a single protocol built for emotional disorders as a group. One example is the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders, developed by David Barlow and colleagues, which targets the shared habit of responding to strong emotions with avoidance; it includes, for example, mindful awareness of emotions and planned exposure to situations that provoke them. In a randomized trial with adults whose principal diagnosis was an anxiety disorder, GAD among them, it worked as well as single-diagnosis CBT protocols, and more participants completed it (Barlow et al., 2017). The therapist guide is published by Oxford University Press and training is offered by the Unified Protocol Institute; deliver it only within your training.

Add disorder-specific work on top of the shared interventions. For GAD: worry exposure, experiments that test tolerance of uncertainty, and a planned reduction in reassurance-seeking and checking. For depression: graded activity scheduling, work on hopelessness, and, for recurrent episodes, a written relapse-prevention plan.

Objectives Measured With the GAD-7 and PHQ-9

Use each measure's total score and its published severity bands. Record the total and the band every time, with the date and the previous total.

MeasureTotal score rangePublished severity bands
GAD-70–210–4 minimal, 5–9 mild, 10–14 moderate, 15–21 severe
PHQ-90–270–4 minimal, 5–9 mild, 10–14 moderate, 15–19 moderately severe, 20–27 severe

The bands are those published by the measures' developers (Spitzer et al., 2006, for the GAD-7; Kroenke, Spitzer and Williams, 2001, for the PHQ-9). Both measures are free to download from the official PHQ screeners site, which also states their terms of use. See outcome measures for more on documenting scores.

  • Write score objectives as movement to a lower band, with a timeframe. "PHQ-9 total from 21 (severe) to below 15 by week 6 and below 10 by week 12" gives you a milestone and a target.
  • Pair every score objective with a behavioral one. Activities per week, workdays attended or reassurance requests per day show function, and function is what medical necessity rests on.
  • Give both measures on the same schedule, even while treatment is focused on one condition, so the other one does not drift unseen.
  • Never let a questionnaire total stand in for a risk assessment. Ask directly about suicidal thoughts at intake and whenever depression scores rise or hopelessness appears, and document what you asked and what you found. See risk assessment and the safety plan.

Sequencing When Both Are Severe

When the GAD-7 and the PHQ-9 are both in the severe range, trying to treat everything at once usually means treating nothing well. A sequence written into the plan keeps sessions focused and shows a reviewer your reasoning.

  1. Put safety and level of care first. Severe depression calls for a direct suicide risk assessment before anything else. If the client cannot work, cannot care for themselves or may not stay safe between sessions, weekly outpatient therapy may not be enough: consider a safety plan, a prompt referral for a medication evaluation, more frequent sessions, or a step up to an intensive outpatient or partial hospitalization program (see IOP and PHP documentation). Depression with psychotic features (F32.3, F33.3) needs psychiatric involvement.
  2. Choose the lead condition and write down why. NICE's GAD guideline advises clinicians to "treat the primary disorder first," which it describes as the one "that is more severe and in which it is more likely that treatment will improve overall functioning" (CG113, recommendation 1.2.8). Its depression guideline adds that "when depression is accompanied by symptoms of anxiety ... the first priority should usually be to treat the depression," and that when "the person has an anxiety disorder and comorbid depression or depressive symptoms," clinicians should "consider treating the anxiety disorder first" (NG222, recommendation 1.2.13). These are UK guidelines, but the logic carries over: lead with the condition causing the most impairment and risk now. When a depressive episode is the main source of impairment, that is usually the depression, even if the anxiety is older; when long-standing GAD is driving the impairment and the low mood has grown out of it, leading with the anxiety may lift both.
  3. Start with what helps both. Psychoeducation about how worry and low mood feed each other, behavioral activation, sleep and routine, and problem-solving can all begin in the first sessions. Severe depression brings low energy and poor concentration, which make demanding cognitive work hard, so behavioral steps usually come first.
  4. Give the second condition a start point. List goals for both diagnoses from the beginning, but give the second set a start date or a trigger, for example "anxiety-focused interventions begin at week 4 or when the PHQ-9 total is below 15, whichever comes first." The plan then shows that both conditions are being addressed, in order.
  5. Coordinate medication care. If you are not the prescriber, a referral for a medication evaluation is within your scope and often appropriate: NICE's depression guideline puts combined individual CBT and an antidepressant first in its list of treatment options for more severe depression. Record the referral, the release of information and each contact with the prescriber; see the letter to a primary care provider.
  6. Re-measure both and revisit the order. If the lead condition has not responded after a fair trial, or the second condition worsens while it waits, change the order or the approach, and document why at the next review.

Sample Treatment Plan

The plan below is fictional. It shows a recurrent depressive episode with long-standing GAD, both in the severe range at intake, with depression leading for the first four weeks.

Sample Treatment Plan: Recurrent Major Depression With Generalized Anxiety Disorder

Client: Elena M. (pseudonym) Date of Plan: 11/09/2026 Target Review Date: 02/08/2027 (13 weeks after the plan date; the client's payer expects plan updates about every three months) Diagnoses:

  1. Major depressive disorder, recurrent, severe without psychotic features (F33.2), listed first as the lead condition for the first phase of treatment
  2. Generalized anxiety disorder (F41.1)

Baseline Measures (11/02/2026): PHQ-9 = 21 (severe); GAD-7 = 16 (severe) Risk: Client reported passive thoughts of death over the past two weeks, with no intent, plan or preparatory behavior and no history of suicide attempts. Safety plan completed 11/02/2026 and reviewed at each session. Protective factors: close relationship with her sister, employment, engagement in treatment. Presenting Concerns: Client, 34, a project coordinator, describes years of persistent worry about her work and money, which she calls "background noise." Her third depressive episode began about six weeks ago, after a reorganization at work. Her mood has not lifted since; she has stopped running and seeing friends, sleeps 4 to 5 hours with early waking, and missed 5 workdays in October. She calls her sister 4 to 6 times a day for reassurance about work decisions. How the Conditions Interact: Evening worry about the next workday delays sleep; short sleep worsens fatigue and low mood; low energy leads her to cancel runs and plans; withdrawal leaves more time to ruminate about past mistakes, which feeds both hopelessness and the next day's worry. Sequencing: Treatment weeks are counted from intake (11/02/2026). Depression leads for the first four weeks because it is driving the greatest impairment (missed work, withdrawal) and the current risk. Shared interventions start at once. Anxiety-focused interventions begin at week 4 or when the PHQ-9 total is below 15, whichever comes first. Referred to her primary care provider for a medication evaluation; release of information on file.


Goal 1 (MDD, F33.2): Reduce depressive symptoms and restore daily activity.

Objective 1.1: Client will reduce her PHQ-9 total from 21 (severe) to below 15 by week 6 and below 10 by week 12, measured at each session.

Objective 1.2: Client will complete at least 4 scheduled activities per week, including 2 runs (baseline: 1 activity per week), as recorded on an activity log, by week 6.

Objective 1.3: Client will attend all scheduled workdays for 4 consecutive weeks (baseline: 5 missed days in October) by week 10.

Interventions for Goal 1:

  • Behavioral activation with a graded weekly activity schedule tied to her stated values of health, friendship and competence at work (also serves Goal 3)
  • Cognitive restructuring of hopeless and self-critical predictions, starting at week 3 (also serves Goal 2)
  • Safety plan review at each session while the PHQ-9 total is 15 or above or any suicidal thinking is reported
  • Coordination with her primary care provider about the medication evaluation and any treatment started
  • Relapse-prevention plan drafted from week 10, given that this is her third episode

Goal 2 (GAD, F41.1): Reduce worry and reassurance-seeking and increase tolerance of uncertainty. (Active from week 4, or earlier if the PHQ-9 total falls below 15.)

Objective 2.1: Client will reduce her GAD-7 total from 16 (severe) to below 10 by week 12, measured at each session.

Objective 2.2: Client will reduce reassurance calls to her sister from 4–6 per day to 1 or fewer, as tracked on a daily log, within 8 weeks of starting anxiety-focused work.

Objective 2.3: Client will complete at least 2 planned uncertainty experiments per week (for example, sending a report after one review instead of four) for 4 consecutive weeks, by week 12.

Interventions for Goal 2:

  • Psychoeducation on the worry cycle and intolerance of uncertainty
  • Scheduled worry period, with worries postponed to it at other times (also serves Goal 3)
  • Behavioral experiments that test her predictions about uncertain outcomes
  • Planned, gradual reduction of reassurance-seeking, agreed with the client and, with her consent, her sister
  • Applied relaxation for physical tension

Goal 3 (Shared): Restore sleep and a stable daily routine.

Objective 3.1: Client will sleep at least 6.5 hours on 5 of 7 nights (baseline: 4 to 5 hours), per sleep diary, by week 8.

Objective 3.2: Client will keep a consistent wake time, within 30 minutes, on 6 of 7 days for 4 consecutive weeks, by week 8.

Interventions for Goal 3:

  • Fixed wake time, stimulus control and a 30-minute wind-down routine that ends with writing down the next day's worries for the scheduled worry period
  • A morning activity from the behavioral activation schedule to anchor the start of each day

Measurement Plan: PHQ-9 and GAD-7 at every session, including each plan review and discharge. Activity log, reassurance log and sleep diary reviewed weekly. Session Frequency: Weekly 53-minute individual sessions Modality: CBT with behavioral activation and worry-focused strategies Estimated Duration of Treatment: 16 to 20 sessions Discharge or Step-Down Criteria: PHQ-9 and GAD-7 totals both below 10 at every session for 6 consecutive weeks, full work attendance, sleep objectives met, and a written relapse-prevention plan in place Client Participation: Client helped develop this plan, agreed with the order of treatment, and received a copy.

This is a sample for educational purposes only — not real patient data.

Progress Tracking: Selected Sessions From the First Six Weeks (Same Fictional Client)

DatePHQ-9GAD-7Functional markersNote
11/02/2026 (intake)21 (severe)16 (severe)1 activity per week; 5 workdays missed in OctoberSafety plan completed
11/30/2026 (week 4)16 (moderately severe)15 (severe)3 activities per week; no missed workdays since intakePassive thoughts of death no longer reported; week-4 start point reached, anxiety-focused work begins this session
12/14/2026 (week 6)13 (moderate)12 (moderate)4 activities per week; 6 or more hours of sleep on 4 nightsObjective 1.1 week-6 milestone met; reassurance calls down to 3 per day

Progress Summary (12/14/2026): Depression has moved from the severe to the moderate band and the client is back at work full time, meeting the week-6 milestone for Objective 1.1. Anxiety has moved from the severe to the moderate band since worry-focused work began; reassurance calls are down from 4–6 to 3 per day. Sleep is improving but has not yet met Objective 3.1. Continue weekly sessions under the current plan until the 02/08/2027 review, or sooner if risk or functioning changes.

This is a sample for educational purposes only — not real patient data.

Try this template in My Clinical WriterDownload Blank Anxiety and Depression Treatment Plan (.docx)

Feedback on this template

anxiety-and-depression-treatment-plan

Please don’t include any client or patient details.

How to Write It Step by Step

Step 1: Confirm both diagnoses and record baselines on the same day. Give the GAD-7 and the PHQ-9 together, describe the functional impairment each condition causes in concrete terms, and document a direct suicide risk assessment. If one diagnosis is still uncertain, hold off on coding it: in outpatient care, ICD-10-CM does not code diagnoses documented as "probable" or "rule out" (Section IV.H). Code the confirmed condition and describe the rest, and see the differential diagnosis template for working through the overlap.

Step 2: Write the formulation that links them. Two or three sentences on how this client's worry, mood, avoidance and sleep affect one another. This is what makes the shared interventions make sense.

Step 3: Decide the order and record the reason. Name the lead condition, the evidence for that choice (severity, risk, which condition is driving the impairment, the client's preference), and when the second set of goals becomes active.

Step 4: Write separate goals, then a shared one. Each objective needs a baseline, a target, a timeframe and a named measure. "Reduce anxiety and depression" is two goals pretending to be one; see SMART goals for treatment plans.

Step 5: Map every intervention to its goals. Write shared interventions once and list the goals they serve. Include only interventions you will actually use, because your progress notes will be read against the plan.

Step 6: Set the measurement schedule and the review date. The minimum review interval comes from your payer, state and setting, not from a universal rule; see how often to update a treatment plan. Re-measure both conditions before each review.

Step 7: Review the plan with the client. Clients often expect both problems to be tackled at once. Explaining the order, and when work on the second condition starts, helps them stay with it. Document their participation and agreement.

Documentation Tips

  • Name the goal in every progress note. "Reviewed activity log (Goals 1 and 3); introduced worry postponement (Goal 2)." This keeps the golden thread running from the plan to each note and claim. For note examples, see progress notes for anxiety and progress notes for depression.
  • Record both scores whenever you give them. Date, total, band and the previous total for each measure, including in sessions focused on one condition.
  • Describe the interaction once. Instead of copying the same observations under each diagnosis, write one sentence on how the two affected each other this week: "Worry about Monday's meeting kept her awake; she skipped her run the next morning."
  • Keep codes and focus in step. Code each session by what it mainly addressed: a session spent on worry and reassurance-seeking lists F41.1 first, even while the depression leads the plan. If the depression improves and the anxiety becomes the main focus of treatment, re-order the diagnoses on the plan at the review. If the depression moves into partial or full remission while you are still treating or monitoring it, the remission codes describe that status: F32.4 or F32.5 for a single episode, F33.41 or F33.42 for recurrent depression. F41.1 has no remission code, so record the status of the anxiety in words and GAD-7 totals.
  • Write down the reasoning for the sequence and for any change to it. A reviewer who reads "anxiety goals start at week 4 because depression is driving current impairment and risk" can follow the plan; a reviewer who finds untouched anxiety goals with no explanation cannot.
  • Record coordination of care. The prescriber's name, the release of information, and the date and content of each contact.
  • Show the need for care for each condition. Tie functional impairment to each diagnosis, so that if one condition improves, the record still shows why treatment continues for the other.

Common Mistakes

Two plans that never mention each other. Separate plans for GAD and depression usually repeat the same interventions under different goals and drift apart at review. Keep one plan with both diagnoses.

One merged goal with one measure. "Reduce anxiety and depression," tracked only with the PHQ-9, cannot show whether the anxiety is improving.

Interventions that are not tied to goals. A list of techniques with no goal numbers leaves a reviewer guessing which condition each one treats.

Measuring only the condition you are treating first. The other condition can worsen unnoticed while it waits. Give both measures on the same schedule.

Coding conflicts. Reporting both a single-episode (F32) and a recurrent (F33) depression code, or adding F41.8, which includes mixed anxiety and depressive disorder, on top of F41.1 and an MDD code for the same symptoms.

Diagnosing GAD from worry that exists only inside a depressive episode. If the worry began with the low mood and fades when mood recovers, it may belong to the depression rather than to a second diagnosis. DSM-5-TR's "with anxious distress" specifier can describe that picture.

An unwritten sequence. If the plan does not say which condition comes first and why, a deferred goal looks like a neglected one.

Writing a treatment plan right now?

My Clinical Writer helps you build treatment plans from your session details in under 60 seconds.

Try This Template Free →

myclinicalwriter.ai

Frequently Asked Questions

External Resources

Authoritative references and tools related to this documentation type.

Stop spending hours on documentation

My Clinical Writer uses AI to help you draft clinical notes, treatment plans, and reports in minutes — not hours.

Try This Template Free →